Literature DB >> 10787178

Cellular signalling by lipoprotein receptors.

J Herz1, M Gotthardt, T E Willnow.   

Abstract

Lipoprotein receptors are commonly thought merely to mediate the internalization of lipoprotein particles or the exchange of lipids at the cell surface. Recent findings have now implicated these multifunctional receptors in cellular signalling mechanisms that extend beyond simple ligand endocytosis. By mediating the cellular uptake of lipophilic vitamins and hormones, megalin, a member of the LDL receptor gene family, regulates critical hormonal and metabolic processes. Other members of the LDL receptor family interact with cytoplasmic adaptor and scaffold proteins, which allows them to transmit signals directly across the plasma membrane of the target cell. This sheds a new light on the emerging roles of lipoprotein receptors in pathologic disease processes such as Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10787178     DOI: 10.1097/00041433-200004000-00009

Source DB:  PubMed          Journal:  Curr Opin Lipidol        ISSN: 0957-9672            Impact factor:   4.776


  11 in total

Review 1.  Lipoprotein receptors and cholesterol in APP trafficking and proteolytic processing, implications for Alzheimer's disease.

Authors:  Maria-Paz Marzolo; Guojun Bu
Journal:  Semin Cell Dev Biol       Date:  2008-10-17       Impact factor: 7.727

Review 2.  Lactoferrin--a novel bone growth factor.

Authors:  Dorit Naot; Andrew Grey; Ian R Reid; Jillian Cornish
Journal:  Clin Med Res       Date:  2005-05

3.  Apolipoprotein E receptor 2 is involved in the thrombotic complications in a murine model of the antiphospholipid syndrome.

Authors:  Zurina Romay-Penabad; Renan Aguilar-Valenzuela; Rolf T Urbanus; Ronald H W M Derksen; Maarten T T Pennings; Elizabeth Papalardo; Tuya Shilagard; Gracie Vargas; Yong Hwang; Philip G de Groot; Silvia S Pierangeli
Journal:  Blood       Date:  2010-11-30       Impact factor: 22.113

4.  Loss of Lrp2 in zebrafish disrupts pronephric tubular clearance but not forebrain development.

Authors:  Esther Kur; Anna Christa; Kerry N Veth; Chandresh R Gajera; Miguel A Andrade-Navarro; Jingjing Zhang; Jason R Willer; Ronald G Gregg; Salim Abdelilah-Seyfried; Sebastian Bachmann; Brian A Link; Annette Hammes; Thomas E Willnow
Journal:  Dev Dyn       Date:  2011-03-31       Impact factor: 3.780

5.  Increased locomotor activity in mice lacking the low-density lipoprotein receptor.

Authors:  Gregory A Elder; Andre Ragnauth; Nathan Dorr; Sonia Franciosi; James Schmeidler; Vahram Haroutunian; Joseph D Buxbaum
Journal:  Behav Brain Res       Date:  2008-04-08       Impact factor: 3.332

Review 6.  Trafficking regulation of proteins in Alzheimer's disease.

Authors:  Shangtong Jiang; Yanfang Li; Xian Zhang; Guojun Bu; Huaxi Xu; Yun-wu Zhang
Journal:  Mol Neurodegener       Date:  2014-01-11       Impact factor: 14.195

7.  Cholesterol-Lowering Gene Therapy Prevents Heart Failure with Preserved Ejection Fraction in Obese Type 2 Diabetic Mice.

Authors:  Joseph Pierre Aboumsallem; Ilayaraja Muthuramu; Mudit Mishra; Bart De Geest
Journal:  Int J Mol Sci       Date:  2019-05-06       Impact factor: 5.923

8.  ApoB100-LDL acts as a metabolic signal from liver to peripheral fat causing inhibition of lipolysis in adipocytes.

Authors:  Josefin Skogsberg; Andrea Dicker; Mikael Rydén; Gaby Aström; Roland Nilsson; Hasanuzzaman Bhuiyan; Sigurd Vitols; Aline Mairal; Dominique Langin; Peteris Alberts; Erik Walum; Jesper Tegnér; Anders Hamsten; Peter Arner; Johan Björkegren
Journal:  PLoS One       Date:  2008-11-20       Impact factor: 3.240

Review 9.  Endocytosis and Physiology: Insights from Disabled-2 Deficient Mice.

Authors:  Wensi Tao; Robert Moore; Elizabeth R Smith; Xiang-Xi Xu
Journal:  Front Cell Dev Biol       Date:  2016-11-25

10.  Dab2 gene variant is associated with increased coronary artery disease risk in Chinese Han population.

Authors:  Yinghong Wang; Yongtao Wang; Dilare Adi; XiaoDong He; Fen Liu; Asiya Abudesimu; Zhenyan Fu; Yitong Ma
Journal:  Medicine (Baltimore)       Date:  2020-07-02       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.